SYRE logo

SYRE

Spyre Therapeutics, Inc.NASDAQHealthcare
$47.58-2.70%ClosedMarket Cap: $2.87B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-31BTIGBuy
2026-03-18StifelBuy
2026-02-20BTIGBuy
2026-02-20Wells FargoOverweight
2026-01-16BTIGBuy
2025-12-01Jones TradingBuy
2025-09-16BTIGBuy
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-3.13$166.7K9
Sun Dec 31$-3.32$200.0K7
Mon Dec 31$-3.67$37.7M2
Tue Dec 31$-3.87$92.3M5